Loading…
Control of the allosteric equilibrium of hemoglobin by cross‐linking agents
The kinetics of ligand rebinding have been studied for modified or cross‐linked hemoglobins (Hbs). Several compounds were tested that interact with α Val 1 or involve a cross‐link between α Val 1 and α Lys 99 of the opposite dimer. By varying the length of certain cross‐linking molecules, a wide ran...
Saved in:
Published in: | Protein science 2002-06, Vol.11 (6), p.1376-1383 |
---|---|
Main Authors: | , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c4826-4fcfab84064ebd427665e38fb3ecc90d88a8ea74e0b51dc150f7e5900a8d6cd63 |
---|---|
cites | cdi_FETCH-LOGICAL-c4826-4fcfab84064ebd427665e38fb3ecc90d88a8ea74e0b51dc150f7e5900a8d6cd63 |
container_end_page | 1383 |
container_issue | 6 |
container_start_page | 1376 |
container_title | Protein science |
container_volume | 11 |
creator | Marden, Michael C. Cabanes‐Macheteau, Marion Babes, Alexandru Kiger, Laurent Griffon, Nathalie Poyart, Claude Boyiri, Telih Safo, Martin K. Abraham, Donald J. |
description | The kinetics of ligand rebinding have been studied for modified or cross‐linked hemoglobins (Hbs). Several compounds were tested that interact with α Val 1 or involve a cross‐link between α Val 1 and α Lys 99 of the opposite dimer. By varying the length of certain cross‐linking molecules, a wide range in the allosteric equilibrium could be obtained. Several of the mono‐aldehyde modified Hbs show a shift toward the high affinity conformation of Hb. At the other extreme, for certain di‐aldehyde cross‐linked Hbs, the CO kinetics are typical of binding to deoxy Hb, even at low photodissociation levels, with which the dominant photoproduct is the triply liganded species; in these cases the hemoglobin does not switch from the low to high affinity state until after the fourth ligand is bound. Although each modified Hb shows only two distinct rates, the kinetic data as a function of dissociation level cannot be simulated with a simple two‐state model. A critical length is observed for the maximum shift toward the low affinity T‐state. Longer or shorter lengths of the cross‐linker yielded more high affinity R‐state. Unlike native Hb, which is in equilibrium with free dimers, the cross‐linked Hbs maintain the fraction slow kinetics, which is unique to Hb tetramers, even at 0.5 μM (total heme). Addition of HbCN to unmodified HbCO solutions results in dimer exchange, which decreases the relative fraction of slow bimolecular kinetics; the cross‐linked Hbs did not show such an effect, indicating that they do not participate in dimer exchange. |
doi_str_mv | 10.1110/ps.4880102 |
format | article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2373633</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>71706784</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4826-4fcfab84064ebd427665e38fb3ecc90d88a8ea74e0b51dc150f7e5900a8d6cd63</originalsourceid><addsrcrecordid>eNp9kMFO3DAQhi1UBMvChQeocuoBKdtx7HWcS6VqRQEJRFVRqTfLcSa7BicOdkK1Nx6hz8iTENhVKZeeRpr_0__P_IQcU5hRSuFzF2dcSqCQ7ZAJ5aJIZSF-fSATKARNJRNynxzEeAsAnGZsj-zTDDLKmZiQq4Vv--Bd4uukX2GinfOxx2BNgveDdbYMdmhe1BU2ful8adukXCcm-BifHv84297ZdpnoJbZ9PCS7tXYRj7ZzSn5-O71ZnKeX12cXi6-XqeEyEymvTa1LyUFwLCue5ULMkcm6ZGhMAZWUWqLOOUI5p5Whc6hznBcAWlbCVIJNyZeNbzeUDVZmzA7aqS7YRoe18tqq90prV2rpH1TGciYYGw0-bQ2Cvx8w9qqx0aBzukU_RJXTHEQu-QiebMDXhwPWf0MoqJf2VRfVtv0R_vjvWW_otu4RoBvgt3W4_o-V-v7jelyxXLBnYzCSVA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>71706784</pqid></control><display><type>article</type><title>Control of the allosteric equilibrium of hemoglobin by cross‐linking agents</title><source>Wiley</source><source>PubMed Central</source><creator>Marden, Michael C. ; Cabanes‐Macheteau, Marion ; Babes, Alexandru ; Kiger, Laurent ; Griffon, Nathalie ; Poyart, Claude ; Boyiri, Telih ; Safo, Martin K. ; Abraham, Donald J.</creator><creatorcontrib>Marden, Michael C. ; Cabanes‐Macheteau, Marion ; Babes, Alexandru ; Kiger, Laurent ; Griffon, Nathalie ; Poyart, Claude ; Boyiri, Telih ; Safo, Martin K. ; Abraham, Donald J.</creatorcontrib><description>The kinetics of ligand rebinding have been studied for modified or cross‐linked hemoglobins (Hbs). Several compounds were tested that interact with α Val 1 or involve a cross‐link between α Val 1 and α Lys 99 of the opposite dimer. By varying the length of certain cross‐linking molecules, a wide range in the allosteric equilibrium could be obtained. Several of the mono‐aldehyde modified Hbs show a shift toward the high affinity conformation of Hb. At the other extreme, for certain di‐aldehyde cross‐linked Hbs, the CO kinetics are typical of binding to deoxy Hb, even at low photodissociation levels, with which the dominant photoproduct is the triply liganded species; in these cases the hemoglobin does not switch from the low to high affinity state until after the fourth ligand is bound. Although each modified Hb shows only two distinct rates, the kinetic data as a function of dissociation level cannot be simulated with a simple two‐state model. A critical length is observed for the maximum shift toward the low affinity T‐state. Longer or shorter lengths of the cross‐linker yielded more high affinity R‐state. Unlike native Hb, which is in equilibrium with free dimers, the cross‐linked Hbs maintain the fraction slow kinetics, which is unique to Hb tetramers, even at 0.5 μM (total heme). Addition of HbCN to unmodified HbCO solutions results in dimer exchange, which decreases the relative fraction of slow bimolecular kinetics; the cross‐linked Hbs did not show such an effect, indicating that they do not participate in dimer exchange.</description><identifier>ISSN: 0961-8368</identifier><identifier>EISSN: 1469-896X</identifier><identifier>DOI: 10.1110/ps.4880102</identifier><identifier>PMID: 12021436</identifier><language>eng</language><publisher>Bristol: Cold Spring Harbor Laboratory Press</publisher><subject>Aldehydes - pharmacology ; Allosteric Regulation - drug effects ; allostery ; Carbon Monoxide - metabolism ; Cross-Linking Reagents - pharmacology ; cross‐link ; Dimerization ; effector ; Fluorescent Dyes ; Hemoglobin ; Hemoglobin A - chemistry ; Hemoglobin A - metabolism ; Humans ; Kinetics ; ligand kinetics ; Oxygen - metabolism ; Protein Conformation - drug effects ; Structure-Activity Relationship</subject><ispartof>Protein science, 2002-06, Vol.11 (6), p.1376-1383</ispartof><rights>Copyright © 2002 The Protein Society</rights><rights>Copyright © Copyright 2002 The Protein Society</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4826-4fcfab84064ebd427665e38fb3ecc90d88a8ea74e0b51dc150f7e5900a8d6cd63</citedby><cites>FETCH-LOGICAL-c4826-4fcfab84064ebd427665e38fb3ecc90d88a8ea74e0b51dc150f7e5900a8d6cd63</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC2373633/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC2373633/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,723,776,780,881,27903,27904,53769,53771</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/12021436$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Marden, Michael C.</creatorcontrib><creatorcontrib>Cabanes‐Macheteau, Marion</creatorcontrib><creatorcontrib>Babes, Alexandru</creatorcontrib><creatorcontrib>Kiger, Laurent</creatorcontrib><creatorcontrib>Griffon, Nathalie</creatorcontrib><creatorcontrib>Poyart, Claude</creatorcontrib><creatorcontrib>Boyiri, Telih</creatorcontrib><creatorcontrib>Safo, Martin K.</creatorcontrib><creatorcontrib>Abraham, Donald J.</creatorcontrib><title>Control of the allosteric equilibrium of hemoglobin by cross‐linking agents</title><title>Protein science</title><addtitle>Protein Sci</addtitle><description>The kinetics of ligand rebinding have been studied for modified or cross‐linked hemoglobins (Hbs). Several compounds were tested that interact with α Val 1 or involve a cross‐link between α Val 1 and α Lys 99 of the opposite dimer. By varying the length of certain cross‐linking molecules, a wide range in the allosteric equilibrium could be obtained. Several of the mono‐aldehyde modified Hbs show a shift toward the high affinity conformation of Hb. At the other extreme, for certain di‐aldehyde cross‐linked Hbs, the CO kinetics are typical of binding to deoxy Hb, even at low photodissociation levels, with which the dominant photoproduct is the triply liganded species; in these cases the hemoglobin does not switch from the low to high affinity state until after the fourth ligand is bound. Although each modified Hb shows only two distinct rates, the kinetic data as a function of dissociation level cannot be simulated with a simple two‐state model. A critical length is observed for the maximum shift toward the low affinity T‐state. Longer or shorter lengths of the cross‐linker yielded more high affinity R‐state. Unlike native Hb, which is in equilibrium with free dimers, the cross‐linked Hbs maintain the fraction slow kinetics, which is unique to Hb tetramers, even at 0.5 μM (total heme). Addition of HbCN to unmodified HbCO solutions results in dimer exchange, which decreases the relative fraction of slow bimolecular kinetics; the cross‐linked Hbs did not show such an effect, indicating that they do not participate in dimer exchange.</description><subject>Aldehydes - pharmacology</subject><subject>Allosteric Regulation - drug effects</subject><subject>allostery</subject><subject>Carbon Monoxide - metabolism</subject><subject>Cross-Linking Reagents - pharmacology</subject><subject>cross‐link</subject><subject>Dimerization</subject><subject>effector</subject><subject>Fluorescent Dyes</subject><subject>Hemoglobin</subject><subject>Hemoglobin A - chemistry</subject><subject>Hemoglobin A - metabolism</subject><subject>Humans</subject><subject>Kinetics</subject><subject>ligand kinetics</subject><subject>Oxygen - metabolism</subject><subject>Protein Conformation - drug effects</subject><subject>Structure-Activity Relationship</subject><issn>0961-8368</issn><issn>1469-896X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2002</creationdate><recordtype>article</recordtype><recordid>eNp9kMFO3DAQhi1UBMvChQeocuoBKdtx7HWcS6VqRQEJRFVRqTfLcSa7BicOdkK1Nx6hz8iTENhVKZeeRpr_0__P_IQcU5hRSuFzF2dcSqCQ7ZAJ5aJIZSF-fSATKARNJRNynxzEeAsAnGZsj-zTDDLKmZiQq4Vv--Bd4uukX2GinfOxx2BNgveDdbYMdmhe1BU2ful8adukXCcm-BifHv84297ZdpnoJbZ9PCS7tXYRj7ZzSn5-O71ZnKeX12cXi6-XqeEyEymvTa1LyUFwLCue5ULMkcm6ZGhMAZWUWqLOOUI5p5Whc6hznBcAWlbCVIJNyZeNbzeUDVZmzA7aqS7YRoe18tqq90prV2rpH1TGciYYGw0-bQ2Cvx8w9qqx0aBzukU_RJXTHEQu-QiebMDXhwPWf0MoqJf2VRfVtv0R_vjvWW_otu4RoBvgt3W4_o-V-v7jelyxXLBnYzCSVA</recordid><startdate>200206</startdate><enddate>200206</enddate><creator>Marden, Michael C.</creator><creator>Cabanes‐Macheteau, Marion</creator><creator>Babes, Alexandru</creator><creator>Kiger, Laurent</creator><creator>Griffon, Nathalie</creator><creator>Poyart, Claude</creator><creator>Boyiri, Telih</creator><creator>Safo, Martin K.</creator><creator>Abraham, Donald J.</creator><general>Cold Spring Harbor Laboratory Press</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>200206</creationdate><title>Control of the allosteric equilibrium of hemoglobin by cross‐linking agents</title><author>Marden, Michael C. ; Cabanes‐Macheteau, Marion ; Babes, Alexandru ; Kiger, Laurent ; Griffon, Nathalie ; Poyart, Claude ; Boyiri, Telih ; Safo, Martin K. ; Abraham, Donald J.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4826-4fcfab84064ebd427665e38fb3ecc90d88a8ea74e0b51dc150f7e5900a8d6cd63</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2002</creationdate><topic>Aldehydes - pharmacology</topic><topic>Allosteric Regulation - drug effects</topic><topic>allostery</topic><topic>Carbon Monoxide - metabolism</topic><topic>Cross-Linking Reagents - pharmacology</topic><topic>cross‐link</topic><topic>Dimerization</topic><topic>effector</topic><topic>Fluorescent Dyes</topic><topic>Hemoglobin</topic><topic>Hemoglobin A - chemistry</topic><topic>Hemoglobin A - metabolism</topic><topic>Humans</topic><topic>Kinetics</topic><topic>ligand kinetics</topic><topic>Oxygen - metabolism</topic><topic>Protein Conformation - drug effects</topic><topic>Structure-Activity Relationship</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Marden, Michael C.</creatorcontrib><creatorcontrib>Cabanes‐Macheteau, Marion</creatorcontrib><creatorcontrib>Babes, Alexandru</creatorcontrib><creatorcontrib>Kiger, Laurent</creatorcontrib><creatorcontrib>Griffon, Nathalie</creatorcontrib><creatorcontrib>Poyart, Claude</creatorcontrib><creatorcontrib>Boyiri, Telih</creatorcontrib><creatorcontrib>Safo, Martin K.</creatorcontrib><creatorcontrib>Abraham, Donald J.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Protein science</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Marden, Michael C.</au><au>Cabanes‐Macheteau, Marion</au><au>Babes, Alexandru</au><au>Kiger, Laurent</au><au>Griffon, Nathalie</au><au>Poyart, Claude</au><au>Boyiri, Telih</au><au>Safo, Martin K.</au><au>Abraham, Donald J.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Control of the allosteric equilibrium of hemoglobin by cross‐linking agents</atitle><jtitle>Protein science</jtitle><addtitle>Protein Sci</addtitle><date>2002-06</date><risdate>2002</risdate><volume>11</volume><issue>6</issue><spage>1376</spage><epage>1383</epage><pages>1376-1383</pages><issn>0961-8368</issn><eissn>1469-896X</eissn><abstract>The kinetics of ligand rebinding have been studied for modified or cross‐linked hemoglobins (Hbs). Several compounds were tested that interact with α Val 1 or involve a cross‐link between α Val 1 and α Lys 99 of the opposite dimer. By varying the length of certain cross‐linking molecules, a wide range in the allosteric equilibrium could be obtained. Several of the mono‐aldehyde modified Hbs show a shift toward the high affinity conformation of Hb. At the other extreme, for certain di‐aldehyde cross‐linked Hbs, the CO kinetics are typical of binding to deoxy Hb, even at low photodissociation levels, with which the dominant photoproduct is the triply liganded species; in these cases the hemoglobin does not switch from the low to high affinity state until after the fourth ligand is bound. Although each modified Hb shows only two distinct rates, the kinetic data as a function of dissociation level cannot be simulated with a simple two‐state model. A critical length is observed for the maximum shift toward the low affinity T‐state. Longer or shorter lengths of the cross‐linker yielded more high affinity R‐state. Unlike native Hb, which is in equilibrium with free dimers, the cross‐linked Hbs maintain the fraction slow kinetics, which is unique to Hb tetramers, even at 0.5 μM (total heme). Addition of HbCN to unmodified HbCO solutions results in dimer exchange, which decreases the relative fraction of slow bimolecular kinetics; the cross‐linked Hbs did not show such an effect, indicating that they do not participate in dimer exchange.</abstract><cop>Bristol</cop><pub>Cold Spring Harbor Laboratory Press</pub><pmid>12021436</pmid><doi>10.1110/ps.4880102</doi><tpages>8</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0961-8368 |
ispartof | Protein science, 2002-06, Vol.11 (6), p.1376-1383 |
issn | 0961-8368 1469-896X |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2373633 |
source | Wiley; PubMed Central |
subjects | Aldehydes - pharmacology Allosteric Regulation - drug effects allostery Carbon Monoxide - metabolism Cross-Linking Reagents - pharmacology cross‐link Dimerization effector Fluorescent Dyes Hemoglobin Hemoglobin A - chemistry Hemoglobin A - metabolism Humans Kinetics ligand kinetics Oxygen - metabolism Protein Conformation - drug effects Structure-Activity Relationship |
title | Control of the allosteric equilibrium of hemoglobin by cross‐linking agents |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-25T21%3A08%3A17IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Control%20of%20the%20allosteric%20equilibrium%20of%20hemoglobin%20by%20cross%E2%80%90linking%20agents&rft.jtitle=Protein%20science&rft.au=Marden,%20Michael%20C.&rft.date=2002-06&rft.volume=11&rft.issue=6&rft.spage=1376&rft.epage=1383&rft.pages=1376-1383&rft.issn=0961-8368&rft.eissn=1469-896X&rft_id=info:doi/10.1110/ps.4880102&rft_dat=%3Cproquest_pubme%3E71706784%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c4826-4fcfab84064ebd427665e38fb3ecc90d88a8ea74e0b51dc150f7e5900a8d6cd63%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=71706784&rft_id=info:pmid/12021436&rfr_iscdi=true |